Vol. 3 No. 2 (2022): July-December

View Vol. 3 No. 2 (2022): July-December

Despite considering COVID-19 as a primarily respiratory disease, the SARS-CoV-2 virus is also an important cause of hepatobiliary diseases.

Published: 2022-07-05

Full Issue

pdf (Español)

Editorial

Hepatobiliary disease in the COVID-19 era

Juan Carlos Restrepo-Gutiérrez

129-130
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.153

Review articles

Cardiomyopathy in patients with liver cirrhosis: review article

Esteban González-Domínguez, Diego Córdova, Paula Abad, Eduardo González, Camila González, Juan José Cordero

131-142
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.154
Hepatobiliary disease associated with COVID-19

Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya

143-154
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.155
Conventional and emerging therapies in primary biliary cholangitis

Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez

155-175
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.156
Hyperbilirubinemia: pathologist's view

Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio

176-190
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.157

Original articles

Histological liver changes caused by chronic intake of monosodium glutamate

Ana Patricia Fabro, María del Carmen Contini, Noelia Villafañe, Adriana Benmelej

191-202
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.158
Primary biliary cholangitis: characterization of a retrospective cohort

Edgar Fernando Ayala-Sierra, Octavio G. Muñoz-Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo

203-217
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.159

Case reports

Hepatic hydrothorax as a rare complication of cirrhosis. A therapeutic challenge in advanced cirrhosis

Melissa Lara-Viáfara, Mauricio Salazar-Moreno, Juliana Suárez-Correa, Oscar Reyna-Carrasco

218-224
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.160
Sclerosing cholangitis associated with severe infection by SARS-CoV-2

Natalia Torres-Vellojín, Juan Camilo Díaz-Duque, Luz Adriana Gómez-Ramírez, Octavio G. Muñoz-Maya

225-232
- pdf (Español)
DOI: https://doi.org/10.52784/27112330.161